Premium
HIV + MALT lymphoma remission induced by highly active antiretroviral therapy alone
Author(s) -
Girard Thomas,
LuquetBesson Isabelle,
BaranMarszak Fanny,
Raphaël Martine,
Boué François
Publication year - 2005
Publication title -
european journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 84
eISSN - 1600-0609
pISSN - 0902-4441
DOI - 10.1111/j.1600-0609.2004.00339.x
Subject(s) - malt lymphoma , lymphoma , helicobacter pylori , medicine , campylobacter jejuni , human immunodeficiency virus (hiv) , antiretroviral therapy , mucosa associated lymphoid tissue , immunology , gastroenterology , viral load , biology , bacteria , genetics
MALT lymphoma is usually described in association with Helicobacter pylori , HCV, HHV8, Campylobacter jejuni or in a setting of overreactive immunity. In HIV + patients, MALT lymphoma is most commonly described in children. We describe here an original case of HIV + MALT lymphoma with bronchial, conjuctival and laryngeal involvement for which a clinical and histopathological remission has been obtained with HAART alone. We conclude that HIV, as well as H. pylori , C. jejuni and HCV can target lymphogenesis in MALT lymphoma.